Skip to content
Smart Market Plus

The Zimbabwean Government Turns Down ‘One-Sided’ US Healthcare Assistance Package Because of Data Concerns

Medical funding image
The offered US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has declined a major American health deal valued at $367m (272 million pounds) over five years due to Washington's request for confidential information.

This rejection was revealed following a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

An official spokesman has since explained that the US was demanding access to biological samples for research and commercial gain but refused to share the benefits from any future medical innovations.

"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has appealed for more negotiations to secure a deal agreeable to both sides so the nation's critical HIV programme can continue.

Broader Context

This development comes after a comparable situation in Kenya, where a high court blocked a similar deal with the US after legal challenges were filed about the safety of Kenyans' health data.

After returning to office last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

USAID had overseen aid for the American government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government deals to boost openness and accountability.

Based on reports, 16 African countries have to date signed these new health pacts, constituting more than $18.3bn in new funding.

Specifics of the Rejected Deal

The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," Tremont commented.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Our nation was requested to surrender its biological resources and data indefinitely, without any corresponding promise of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," his statement read.

"Effectively, our country would supply the basic resources for medical research with no assurance that the end products would be available to our citizens should a future health crisis arise."

National Interest and Global Health

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting structures previously set up through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage future global health emergencies.

"This mechanism is intended to guarantee that when a nation provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."

Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage further discussions with our US partners on how subsequent co-operation could be structured in a manner that respects the sovereignty and interests of both nations."

Medical Community Reaction

A leading public health body expressed it acknowledged the official position, but urged that talks should continue since a large portion of the country's Aids initiatives relied on external financing.

"If technical issues arise, including those relating to information security or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it added.

This impasse emphasises the complex challenges between accepting crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.

The writer

James Costa

Lena is een ervaren marketingspecialist en gepassioneerd over duurzaam winkelen en budgetvriendelijke tips.

Smart Market Plus

Type to search articles.